An in-depth look to GL PHARM TECH CORP. operating, investing, and financing activities

204840 free cash flow for Q3 24 is -827.3 M KRW. For 2023, 204840 free cash flow was -4.34 B KRW and operating cash flow was -3.76 B KRW.